TABLE 1.
In vitro susceptibility of Candida isolates tested in the present study
| Isolates | Median (range) values in mg/L | |
|---|---|---|
| Amphotericin B (AMB) | ||
| EUCAST | CLSI | |
| C. albicans K1 | 0.25 (0.25) | 0.25 (0.25) |
| C. albicans SSI-2699a | >16 (>16) | >16 (>16) |
| C. glabrata 1 | 0.125 (0.125–0.25) | 0.25 (0.125–0.25) |
| C. glabrata 2 | 0.5 (0.25–0.5) | 0.5 (0.25–0.5) |
| C. glabrata 3 | 0.5 (0.25–1) | 1 (1) |
| C. glabrata 4 | 1 (0.5–1) | 1 (0.5–2) |
| C. parapsilosis 1 | 0.25 (0.25) | 0.25 (0.25) |
| C. parapsilosis 2 | 0.5 (0.5) | 0.5 (0.5) |
| C. krusei 1 | 0.5 (0.5) | 0.5 (0.5) |
| C. krusei 2 | 1 (1) | 1 (1) |
SSI, Statens Serum Institut.